OSE IMMUNOTHERAPEUTICS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.56 EUR | -0.71% |
|
+3.35% | +29.91% |
| Apr. 17 | OSE: licensing agreement with AbbVie enters into force | CF |
| Apr. 17 | OSE Immunotherapeutics Finalizes Drug License, Collaboration Deal With AbbVie | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 5.970 | 5.970 | 6.680 |
| Spread/Res. | -6.87% | -6.87% | -16.77% |
| Spread/Supp. | +6.92% | +20.35% | +41.12% |
| Support | 5.200 | 4.620 | 3.940 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- OSE Stock
- Charts OSE Immunotherapeutics
